基于转录组学的川芎嗪改善增生性瘢痕机制研究

2021-12-18 15:24:22王婷吴东芝武雪
安徽农业科学 2021年23期

王婷 吴东芝 武雪

摘要 [目的]基于转录组学分析川芎嗪治疗增生性瘢痕的分子机制。 [方法]获取临床手术的增生性瘢痕组织,利用组织块培养法培养分离瘢痕成纤维细胞,分为对照组和川芎嗪组(10 mg/mL)。采用转录组学测序技术及 GO、KEGG 通路富集分析,研究增生性瘢痕成纤维细胞各基因的表达。 [结果]转录组学分析结果得到川芎嗪参与调控2 783个差异基因,GO及 KEGG 通路富集分析显示以上基因主要富集于DNA复制,细胞周期,类固醇生物合成错配修复,p53信号通路,蛋白质的消化吸收,不饱和脂肪酸的生物合成等通路。[结论]该研究揭示调控成纤维细胞的相关调控蛋白,对阐明川芎嗪防治增生性瘢痕的具体作用机制提供了重要信息。

关键词 川芎嗪;转录组;高通量测序;增生性瘢痕

中图分类号 R 285  文献标识码 A

文章编号 0517-6611(2021)23-0133-04

doi:10.3969/j.issn.0517-6611.2021.23.036

The Mechanism of Tetramethylpyrazine in Improving Hypertrophic Scar Based on Transcriptomics

WANG Ting1,WU Dong-zhi2,WU Xue2

(1.College of Pharmacy,Shaanxi University of Chinese Medicine,Xianyang,Shaanxi 712000;2.Shaanxi University of Chinese Medicine,Xianyang,Shaanxi 712000)

Abstract [Objective]The molecular mechanism of tetramethylpyrazine in the treatment of hypertrophic scar was analyzed based on transcriptomics.[Method]Hypertrophic scar tissue from clinical operation was obtained,and scar fibroblasts were cultured and separated by tissue block culture method,and divided into control group and tetramethylpyrazine group (10 mg/mL).Transcriptome sequencing technology and GO KEGG pathway enrichment analysis were used to study the gene expression of hypertrophic scar fibroblasts.[Result]Transcriptome analysis showed that tetramethylpyrazine was involved in the regulation of 2 783 differential genes,and enrichment analysis of GO and KEGG pathways showed that the above genes were mainly concentrated in DNA replication,cell cycle,steroid biosynthesis mismatch repair,p53 signaling pathway,protein digestion and absorption,unsaturated fatty acid biosynthesis and other pathways.[Conclusion]This study reveals the related regulatory proteins that regulate fibroblasts and provides important information for clarifying the specific mechanism of tetramethylpyrazine in preventing and treating hypertrophic scar.

Key words Tetramethylpyrazine;Transcriptomics;High-throughput sequencing;Hypertrophic scar

基金項目 教育厅专项科研计划项目(18JK0212)。

作者简介 王婷(1996—),女,重庆人,硕士研究生,研究方向:抗结肠癌药物。通信作者,实验师,硕士,从事增生性瘢痕的防治和发生机制研究。

收稿日期 2021-06-01

增生性瘢痕是皮肤烧伤、创伤、手术后最常见的并发症之一,每年新增患者达数百万[1]。作为一种严重的皮肤纤维化疾病,不仅影响美观,危害患者的生理和心理健康,甚至会引起严重的功能障碍,给家庭和社会带来沉重的负担[2]。尽管临床上有多种治疗方案,但因增生性瘢痕的发病率、复发率高及治疗周期长等特点,加之目前缺乏预防瘢痕形成及改善瘢痕的特效药物。因此,增生性瘢痕是临床治疗面临的一大难题,成为国内外学者研究的重点和难点。……

登录APP查看全文